CASP3 and urinary bladder carcinoma: Western blot analysis demonstrates that BIX-01294 (0, 5, 10 μmol/l) significantly activated CASP8, CASP9, CASP3 and cleaved the substrate of CASP3, PARP1 in bladder cancer cells treated for 24 hours (Figure 1B).